Date of Conferral
3-14-2024
Date of Award
March 2024
Degree
Ph.D.
School
Social Work
Advisor
Angela Wood
Abstract
The opioid epidemic is a public health concern that impacts thousands of individuals across the United States. There was a lack of clear understanding of what leads opioid addicts to decline use of medication-assisted treatment (MAT) with injectable extended release naltrexone (XR-NTX). The purpose of this quantitative cross-sectional correlational study was to examine the relationships between past XR-NTX status and demographic factors (gender, age, race, education level, time sober in days, and employment status) and the attitudes about encouragement from providers about engaging in MAT, as well as perceptions about MAT in individuals currently in a MAT who chose not to use XR-NTX in that treatment. The theory of reasoned action provided the framework for the study. Survey data were collected from 114 participants with primary or secondary opioid use disorders recruited from outpatient treatment providers who offer MAT with the use of injectable XR-NTX. Results of multiple logistic regression showed that age was correlated with attitudes about encouragement from providers, and work status was correlated with perceptions about MAT. Past use of XR-NTX was not correlated with perceptions or attitudes. Results could positively impact treatment approaches to reach opioid addicts who choose not to engage in MAT with the use of injectable XR-NTX.
Recommended Citation
Schultz, Heather, "Barriers to the Use of Injectable Naltrexone in an Outpatient Setting" (2024). Walden Dissertations and Doctoral Studies. 15505.
https://scholarworks.waldenu.edu/dissertations/15505
